S&P 500 made big call on SpaceX IPO. Index investors need to know it

Americans have a significant amount of money invested in passive S&P 500 Index funds, with Vanguard and BlackRock managing nearly $2 trillion in assets. The Vanguard ETF (VOO) recently surpassed $1 trillion in assets, highlighting the popularity of this investment option for retirement savings.

However, despite the widespread appeal of S&P 500 Index funds, retail investors looking to invest in SpaceX shares will not find them included in these funds anytime soon. The index committee responsible for determining which stocks are included in the S&P 500 Index has decided to exclude SpaceX from the index for at least the first year of its public market trading.

This decision comes at a time when mega-cap stocks like SpaceX, OpenAI, and Anthropic are expected to make significant waves in the market with their IPOs. While other market benchmarks like the Nasdaq and Russell have updated their rules to accommodate new IPOs, the S&P 500 Index has chosen to maintain its standard 12-month waiting period for new stock inclusion.

As a result, investors seeking exposure to SpaceX will need to look beyond traditional S&P 500 Index funds and consider alternative options like the NASDAQ 100 or the Russell 1000. While SpaceX shares began trading at a value above $2 trillion on the Nasdaq, investors holding ETFs like VOO or IVV will have to wait until at least mid-2027 for SpaceX exposure.

Peter Haynes, head of index and market structure research at TD Securities, expressed disagreement with the index committee’s decision to exclude SpaceX from the S&P 500 Index. He argued that other global benchmarks have created fast-track models for adding sizable stocks like SpaceX to their indexes shortly after IPOs, and U.S. benchmarks should follow suit.

Despite the exclusion of SpaceX from the S&P 500 Index, there are still ways for investors to gain exposure to the company through thematic space and tech innovation ETFs that hold pre-IPO direct stakes in SpaceX. Additionally, new leveraged ETFs are being launched to offer up to 2x daily performance of SpaceX shares, providing bullish and bearish betting options for risk-oriented investors.

While the decision to exclude SpaceX from the S&P 500 Index may disappoint some investors, ETF managers are expected to explore creative solutions to meet investor demand for exposure to innovative companies like SpaceX, OpenAI, and Anthropic. The ETF industry remains dynamic and adaptable, offering a range of investment options to suit different investor preferences and risk profiles. The world of technology is constantly evolving, with new advancements and innovations being made every day. One such advancement that has taken the tech world by storm is the development of artificial intelligence (AI). AI is a branch of computer science that aims to create intelligent machines that can perform tasks that typically require human intelligence, such as speech recognition, decision making, and problem solving.

One area where AI has made a significant impact is in the field of healthcare. AI-powered technologies are being used to improve patient care, enhance diagnosis accuracy, and streamline administrative tasks. One of the key benefits of AI in healthcare is its ability to analyze vast amounts of data quickly and accurately, leading to more precise and personalized treatment plans for patients.

AI is also being used in medical imaging, where it can help radiologists detect and diagnose diseases such as cancer at an early stage. By analyzing images from MRI scans, X-rays, and CT scans, AI algorithms can identify patterns and anomalies that may be missed by human eyes, helping doctors make more informed decisions about patient care.

In addition to medical imaging, AI is being used in drug discovery and development. By analyzing vast amounts of data on chemical compounds, AI algorithms can identify potential drug candidates more efficiently than traditional methods, reducing the time and cost of bringing new drugs to market. This has the potential to revolutionize the pharmaceutical industry and bring new treatments to patients faster than ever before.

AI is also being used in telemedicine, where patients can consult with healthcare providers remotely through video calls and chatbots. This has become especially important during the COVID-19 pandemic, as it allows patients to receive care without having to visit a healthcare facility in person, reducing the risk of exposure to the virus.

Despite the many benefits of AI in healthcare, there are also challenges and concerns that need to be addressed. These include issues related to data privacy and security, as well as the potential for bias in AI algorithms. It is important for healthcare providers to implement robust data protection measures and ensure that AI systems are designed and trained in a fair and unbiased manner.

Overall, AI has the potential to revolutionize the healthcare industry and improve patient outcomes. By harnessing the power of AI, healthcare providers can deliver more personalized and efficient care to patients, leading to better health outcomes and a brighter future for the field of medicine.